Indian Journal of Anaesthesia  
About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions
Home | Login  | Users Online: 212  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size    




 
 Table of Contents    
LETTER TO EDITOR
Year : 2013  |  Volume : 57  |  Issue : 1  |  Page : 91-92  

Rocuronium and sugammadex and rapid emerge in day-care surgery


1 Department of Anaesthesiology and Pain Medicine, Martini General Hospital Groningen, Groningen, The Netherlands
2 Department of Anaesthesiology, Radboud University Medical Centre Nijmegen, The Netherlands

Date of Web Publication14-Mar-2013

Correspondence Address:
H D de Boer
Department of Anaesthesiology and Pain Medicine, Martini General Hospital Groningen, RM Groningen
The Netherlands
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-5049.108588

Rights and Permissions

How to cite this article:
de Boer H D, Booij L. Rocuronium and sugammadex and rapid emerge in day-care surgery. Indian J Anaesth 2013;57:91-2

How to cite this URL:
de Boer H D, Booij L. Rocuronium and sugammadex and rapid emerge in day-care surgery. Indian J Anaesth [serial online] 2013 [cited 2019 Dec 9];57:91-2. Available from: http://www.ijaweb.org/text.asp?2013/57/1/91/108588

Sir,

With great interest we read the review on rapid emergence of day-care anaesthesia by Gangadhar and co-workers. [1] In their review the authors describe the controversies in patient selection with comorbidities, preoperative assessment, anaesthesia techniques and some important post-operative issues of discharge criteria in day-care patients. Furthermore, they briefly discuss the drawbacks of the use of neuromuscular blocking agents (NMBAs) and describe that in patients with neuromuscular disorders general anaesthesia with neuromuscular block (NMB) may have prolonged or unpredictable effects and that the use of total intravenous anaesthesia in day-care surgery avoids the risk of residual paralysis.

Neuromuscular management as a part of balanced anaesthesia should consist a choice of an adequate NMBA, objective neuromuscular monitoring, and reversal of NMB. NMBAs agents are key components in modern anaesthesia to facilitate endotracheal intubation and create optimal surgical conditions, day-care surgery is no exception to this.

Depolarizing and various non-depolarizing NMBAs are used in day-care surgery, but the ideal NMBA should have a rapid onset, minimal side-effects, and a rapid and reliable recovery to avoid postoperative residual curarization (PORC) which may lead to interference with day-care process. Rocuronium is well known to have a rapid onset, creates optimal intubation conditions, and has minimal undesirable side-effects. However, the use of NMBAs, including rocuronium, in general is associated with PORC as the physiological consequences of residual paralysis, such as upper-airway collapse, abnormal swallowing, and respiratory impairment, are leading to increased post-operative morbidity and mortality. [2],[3] Reversal of NMB is therefore necessary to avoid PORC.

Sugammadex, the first selective relaxant binding agent, is able to reverse a rocuronium-induced NMB very rapidly and effectively at any level of NMB without signs of PORC or recurarization. The reversal with sugammadex is not only faster, more efficient, and reliable, but also without the well known undesirable side-effects frequently seen with cholinesterase inhibitors as sugammadex has no direct or indirect action on the components of cholinergic transmission. The combination of rocuronium-sugammadex has shown its efficacy and safety in healthy patients, also in more vulnerable patients, like patients with cardiac, pulmonary disease, and in patients with a neuromuscular disorder. [4],[5]

Patients with neuromuscular disorders can be a challenge to anaesthesiologists and although there is difference in aetiology, these patients are more sensitive to non-depolarizing NMBAs which may lead to a prolonged NMB and PORC, and concomitant morbidity and mortality. The combination of rocuronium-sugammadex has been used successfully in patients with neuromuscular disorders like myasthenia gravis. [5] Rocuronium can be used for rapid onset of NMB to facilitate a rapid endotracheal intubation to protect the airway and sugammadex and can provide a rapid and safe reversal thereby reducing the risk of PORC.

One of these advances in anaesthesia is the introduction of sugammadex. The use of rocuronium provides optimal intubation conditions and surgical relaxation and reversal with sugammadex minimizes the risk of PORC and its related morbidity and mortality. Besides it has been demonstrated that intubation without the use of muscle relaxants leads to less optimal intubating conditions and higher risk of damage to the vocal cords and larynx. [6] Thus, the use of muscle relaxants is advisable in day-care anaesthesia. Therefore, when in day-care surgery endotracheal intubation and surgical relaxation is needed neuromuscular management should preferably constist of the use of the combination of rocuronium-sugammadex and careful objective monitoring of NMB. This results in a rapid recovery of NMB without the risk of the dangerous PORC and related morbidity and mortality.

 
   References Top

1.Gangadhar SB, Gopal TM, Paramesh KS. Rapid emergence of day-care anaesthesia: A review. Indian J Anaesth 2012;56:336-41.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008;107:130-7.  Back to cited text no. 2
[PUBMED]    
3.Plaud B, Debaene B, Donati F, Marty J. Residual paralysis after emergence from anesthesia. Anesthesiology 2010;112:1013-22.  Back to cited text no. 3
[PUBMED]    
4.de Boer HD. Neuromuscular transmission: New concepts and agents. J Crit Care 2009;24:36-42.  Back to cited text no. 4
[PUBMED]    
5.de Boer HD, van Egmond J, Driessen JJ, Booij LH. A new approach to anesthesia management in myasthenia gravis: Reversal of neuromuscular blockade by sugammadex. Rev Esp Anestesiol Reanim 2010;57:181-4.  Back to cited text no. 5
[PUBMED]    
6.Mencke T, Echternach M, Kleinschmidt S, Lux P, Barth V, Plinkert PK, et al. Laryngeal morbidity and quality of tracheal intubation: A randomized controlled trial. Anesthesiology 2003;98:1049-56.  Back to cited text no. 6
[PUBMED]    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed1287    
    Printed50    
    Emailed0    
    PDF Downloaded472    
    Comments [Add]    

Recommend this journal